Imiquimod‐enhanced immunotherapy with diphencyprone for patients with alopecia areata
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15516
Abstract: Topical immunotherapy with dyphencyprone (DPCP) is widely used in patients with alopecia areata (AA). It can produce a contact dermatitis that is believed to decrease Th1 response, predominant in AA. It has been shown that… read more here.
Keywords: enhanced immunotherapy; patients alopecia; dpcp; immunotherapy diphencyprone ... See more keywords